STROK3 White Papers

Optimizing Door-to-Needle Times in Stroke Care
Rapid treatment is critical in stroke care, with faster door-to-needle (DTN) times directly linked to better patient outcomes and reduced healthcare costs. This white paper outlines proven strategies to reduce DTN times, including dedicated stroke teams, EMS pre-notification, direct-to-CT transport, "pit stop" triage models, CT-based tPA administration, and streamlined lab/pharmacy workflows. It also proposes a mobile app to support EMS assessments and hospital coordination. Together, these interventions can significantly improve stroke response efficiency, saving lives and resources. Read the paper.

The Clinical and Financial Impact for Reducing Door-to-Needle Time in Stroke Care
‍Reducing door-to-needle (DTN) time in acute ischemic stroke treatment significantly improves patient outcomes and generates meaningful financial benefits for hospitals. Administering intravenous thrombolytic therapy (IV tPA) quickly leads to reduced complications, shorter hospital stays, and lower demand for post-acute services—all of which translate into increased operational efficiency and improved revenue potential. Hospitals that adopt streamlined DTN protocols, invest in team training, and leverage telestroke solutions can gain both clinical and financial advantages. Read the paper.

The Financial Advantage of Rapid Stroke Treatment for Hospitals
Stroke is a leading cause of morbidity and mortality worldwide, placing significant burdens on healthcare systems. Hospitals that prioritize rapid stroke treatment, particularly through faster administration of thrombolysis and endovascular therapy, can realize substantial financial advantages. These benefits include reduced hospital length of stay (LOS), decreased complications, fewer readmissions, higher reimbursement rates, and improved resource allocation. This paper outlines the financial rationale for hospitals to invest in accelerating stroke treatment. Read the paper.

The Clinical and Economic Imperative of Reducing Door-to-Needle Time
Timely administration of thrombolytic therapy in acute ischemic stroke is a critical determinant of patient outcomes. Delays in door-to-needle (DTN) time correlate with increased morbidity, mortality, and healthcare expenditures. This paper synthesizes recent evidence on the impact of DTN time reduction and explores the role of STROK3 in addressing systemic inefficiencies. By leveraging structured pre-hospital assessments, STROK3 enhances workflow efficiency, facilitates earlier intervention, and improves clinical outcomes. Read the paper.

Accelerating Stroke Care: The Case for STROK3
‍STROK3 is a web-based platform that enhances stroke care by enabling first responders to securely collect and transmit key patient information—including video and audio stroke assessments, demographics, contraindication checklists, and next-of-kin contacts—to hospitals ahead of arrival. This early transmission allows medical teams to make critical decisions sooner, such as routing patients directly to CT scans or initiating consent procedures. By streamlining communication and assessment before the patient reaches the hospital, STROK3 reduces treatment delays, supports faster door-to-needle times, and ultimately improves patient outcomes and recovery prospects. Read the paper.